BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6167541)

  • 1. A public antigenic determinant in the HLA-B5 cross-reacting group--a basis for cross-reactivity and a possible link with Behcet's disease.
    Schwartz BD; Luehrman LK; Lee J; Rodey GE
    Hum Immunol; 1980 Jul; 1(1):37-54. PubMed ID: 6167541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Public antigenic determinant on a family of HLA-B molecules.
    Schwartz BD; Luehrman LK; Rodey GE
    J Clin Invest; 1979 Oct; 64(4):938-47. PubMed ID: 90060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA serological cross-reactivity: HLA-B15 has two public antigens.
    Schwartz BD; Luehrman LK; Lee T; Rodey GE
    Hum Immunol; 1980 Dec; 1(4):331-45. PubMed ID: 6167552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA public determinants are target antigens of cell-mediated cytotoxicity.
    Schwartz BD; Luehrman LK; Rodey GE
    J Exp Med; 1980 Aug; 152(2 Pt 2):340s-350s. PubMed ID: 6157769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association between HLA B5 and ocular involvement in Behçet's disease in southern Turkey.
    Soylu M; Ersöz TR; Erken E
    Acta Ophthalmol (Copenh); 1992 Dec; 70(6):786-9. PubMed ID: 1488888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA antigens and linkage disequilibrium patterns in Turkish Behçet's patients.
    Alpsoy E; Yilmaz E; Coşkun M; Savaş A; Yeğin O
    J Dermatol; 1998 Mar; 25(3):158-62. PubMed ID: 9575677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The histocompatibility antigens in patients with Behçet's disease.
    Haim S; Gideoni O; Barzilai A
    Acta Derm Venereol; 1977; 57(3):243-5. PubMed ID: 71830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epitopes within the HLA-B5,B35 cross-reacting group.
    Ward FE; Stewart AD; Ruiz RE; Killian P; Amos DB; Johnson AH; Kostyu DD
    Hum Immunol; 1989 Nov; 26(3):151-67. PubMed ID: 2481660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Behçet's syndrome with HLA-B5 in the Mexican mestizo population.
    Lavalle C; Alarcon-Segovia D; Del Giudice-Knipping JA; Fraga A
    J Rheumatol; 1981; 8(2):325-7. PubMed ID: 7230164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behçet's disease: lack of correlation of clinical manifestations with HLA antigens.
    Müftüoğlu AU; Yazici H; Yurdakul S; Pazarli H; Ozyazgan Y; Tüzün Y; Altaç M; Yalçin B
    Tissue Antigens; 1981 Feb; 17(2):226-30. PubMed ID: 7233417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Behçet's disease and HLA antigens--an association with a new specificity recognized by a monoclonal antibody].
    Nakayama T
    Hokkaido Igaku Zasshi; 1985 Sep; 60(5):643-52. PubMed ID: 2416665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The high prevalence of HLA-B5 in Behçet's disease.
    Yazici H; Akokan G; Yalçin B; Müftüoğlu A
    Clin Exp Immunol; 1977 Nov; 30(2):259-61. PubMed ID: 606446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Close association of HLA-Bw51 with Behçet's disease.
    Ohno S; Ohguchi M; Hirose S; Matsuda H; Wakisaka A; Aizawa M
    Arch Ophthalmol; 1982 Sep; 100(9):1455-8. PubMed ID: 6956266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA antigens: rabbit antisera reacting with all A series or all B series specificities.
    Cresswell P; Ayres JL
    Eur J Immunol; 1976 Feb; 6(2):82-8. PubMed ID: 786698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship of HLA-B and DR phenotypes to Behcet's syndrome, recurrent oral ulceration and the class of immune complexes.
    Lehner T; Welsh KI; Batchelor JR
    Immunology; 1982 Dec; 47(4):581-7. PubMed ID: 6958639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of HLA phenotype to immunoglobulin class present in immune complexes from patients with Behçet's syndrome.
    Lehner T; Welsh KL; Batchelor JR
    Tissue Antigens; 1981; 17(4):357-61. PubMed ID: 7330844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An immunogenetic basis for the tissue involvement in Behçet's syndrome.
    Lehner T; Batchelor JR; Challacombe SJ; Kennedy L
    Immunology; 1979 Aug; 37(4):895-900. PubMed ID: 500134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The HLA--B14 cross-reactive group.
    Darke C
    Tissue Antigens; 1980 Apr; 15(4):389-97. PubMed ID: 7466779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Significant associations of HLA-B*5101 and B*5108, and lack of association of class II alleles with Behçet's disease in Italian patients.
    Kera J; Mizuki N; Ota M; Katsuyama Y; Pivetti-Pezzi P; Ohno S; Inoko H
    Tissue Antigens; 1999 Dec; 54(6):565-71. PubMed ID: 10674970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA antigens in a family with Behçet's syndrome.
    Fallingborg J; Ambrosius Christensen L; Grunnet N
    Acta Med Scand; 1986; 220(4):375-8. PubMed ID: 3799242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.